title: Epidemiological trends of pre-malignant gastric lesions: a long-term nationwide study in the Netherlands.
abstract: BACKGROUND
  The pre-malignant gastric lesions atrophic gastritis (AG), intestinal metaplasia (IM) and dysplasia (DYS) have long been identified as principal risk factors for gastric cancer.
  
  
  OBJECTIVE
  To evaluate epidemiological time trends of pre-malignant gastric lesions in the Netherlands.
  
  
  METHODS
  Patients with a first diagnosis of AG, IM or DYS between 1991 and 2005 were identified in the Dutch nationwide histopathology registry. The number of new diagnoses per year were evaluated relative to the total number of patients with a first gastric biopsy. Time trends were evaluated with age-period-cohort models using logistic regression analysis.
  
  
  RESULTS
  In total, 23 278 patients were newly diagnosed with AG, 65 937 patients with IM, and 8517 patients with DYS. The incidence of AG declined similarly in men and women with 8.2% per year [95% CI 7.9% to 8.6%], and DYS with 8.1% per year [95% CI 7.5% to 8.6%]. The proportional number of new IM cases declined with 2.9% per year [95% CI 2.7% to 3.1%] in men and 2.4% [95% CI 2.2% to 2.6%] in women. With age-period-cohort models a cohort phenomenon was demonstrated for all categories of pre-malignant gastric lesions in men and in women with IM and DYS. Period phenomena with a larger decline in number of diagnoses after 1996 were also demonstrated for AG and IM.
  
  
  CONCLUSIONS
  The incidence of pre-malignant gastric lesions is declining. Period and cohort phenomena were demonstrated for diagnoses of AG and IM. These findings imply that a further decrease of at least 24% in the incidence of gastric cancer in the coming decade may be anticipated in Western countries without specific intervention.
authors: Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands. A.C.deVries@erasmusmc.nl
authors: A C
authors: AC
authors: de Vries
authors: G A
authors: GA
authors: Meijer
authors: C W N
authors: CW
authors: Looman
authors: M K
authors: MK
authors: Casparie
authors: B E
authors: BE
authors: Hansen
authors: N C T
authors: NC
authors: van Grieken
authors: E J
authors: EJ
authors: Kuipers
mesh_terms: D000328:Adult; D017677:Age Distribution; D000368:Aged; D000369:Aged, 80 and over; D004812:Epidemiologic Methods; D005260:Female; D005753:Gastric Mucosa / Q000473:pathology; D005757:Gastritis, Atrophic / Q000453:epidemiology; D006801:Humans; D008297:Male; D008679:Metaplasia; D008875:Middle Aged; D009426:Netherlands / Q000453:epidemiology; D011230:Precancerous Conditions / Q000453:epidemiology*; D017678:Sex Distribution; D013274:Stomach Neoplasms / Q000453:epidemiology*
references: Am J Surg Pathol. 2000 Feb;24(2):167-76
references: 10680883
references: Cell Oncol. 2007;29(1):19-24
references: 17429138
references: Am J Gastroenterol. 2001 May;96(5):1402-8
references: 11374674
references: Gut. 2001 Sep;49(3):347-53
references: 11511555
references: N Engl J Med. 2001 Sep 13;345(11):784-9
references: 11556297
references: BMJ. 2001 Dec 15;323(7326):1413-6
references: 11744568
references: Bull World Health Organ. 2002;80(1):26-32
references: 11884970
references: Gut. 2002 Jul;51(1):130-1
references: 12077106
references: Aliment Pharmacol Ther. 2002 Jul;16(7):1249-59
references: 12144574
references: Eur J Gastroenterol Hepatol. 2003 Aug;15(8):885-91
references: 12867799
references: Scand J Gastroenterol. 2003 Sep;38(9):938-41
references: 14531529
references: Cancer Epidemiol Biomarkers Prev. 2004 Mar;13(3):468-76
references: 15006925
references: Am J Dig Dis. 1973 Dec;18(12):1061-5
references: 4761527
references: Scand J Gastroenterol. 1974;9(5):441-6
references: 4850688
references: JAMA. 1980 Feb 22-29;243(8):756-62
references: 6986000
references: Histopathology. 1986 Dec;10(12):1271-7
references: 3817762
references: Stat Med. 1987 Jun;6(4):449-67
references: 3629047
references: Stat Med. 1987 Jun;6(4):469-81
references: 3629048
references: J Med Microbiol. 1990 Jun;32(2):105-9
references: 2355391
references: J Natl Cancer Inst. 1992 Aug 19;84(16):1261-6
references: 1640486
references: Cancer Res. 1992 Dec 15;52(24):6735-40
references: 1458460
references: Lancet. 1993 Aug 7;342(8867):328-31
references: 8101585
references: Gut. 1994 Sep;35(9):1167-71
references: 7959219
references: IARC Monogr Eval Carcinog Risks Hum. 1994;61:1-241
references: 7715068
references: Eur J Gastroenterol Hepatol. 1994 Dec;6 Suppl 1:S79-83
references: 7735941
references: Lancet. 1995 Jun 17;345(8964):1525-8
references: 7791437
references: Hum Pathol. 1996 Jan;27(1):35-41
references: 8543308
references: Am J Surg Pathol. 1996 Oct;20(10):1161-81
references: 8827022
references: Am J Gastroenterol. 1997 Sep;92(9):1480-2
references: 9317067
references: Histopathology. 1999 Apr;34(4):320-5
references: 10231399
references: Am J Gastroenterol. 2005 Mar;100(3):568-76
references: 15743353
references: Gut. 2005 Aug;54(8):1062-6
references: 15857935
references: Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1083-94
references: 16775164
references: Gut. 2000 Aug;47(2):251-5
references: 10896917
references: J Clin Pathol. 1999 Aug;52(8):612-5
references: 10645232
references: Eur J Gastroenterol Hepatol. 2007 Mar;19(3):213-6
references: 17301647